Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The deal will lift the company’s annual recurring sales by 35%
Thursday 17 Aug 2017 Author: Lisa-Marie Janes

Hospital equipment monitoring specialist LiDCO (LID:AIM) has scored its first US customer for its high usage programme. The undisclosed customer, one of the world’s largest cancer hospitals, signed a deal for 44 monitors to check the amount of blood flowing around the body.

On an annualised basis the contract should result in a 35% uplift in LiDCO’s annual recurring revenue in the US. Year-to-date shares in the company are up nearly 50% at 8.8p.

‹ Previous2017-08-17Next ›